GABAPENTIN- gabapentin capsule 
RedPharm Drug, Inc.

----------

GABAPENTIN 300MG

HOW SUPPLIED

100 mg Capsules (White/White colored, size '3' hard gelatin capsules with "103" printed on body of capsules containing white to off white granular powder) Bottles of 100 & 500

HOW SUPPLIED

300 mg Capsules (Yellow/Yellow colored, size '1' hard gelatin capsules with "104" printed on body of capsules containing white to off white granular powder) Bottles of 100 & 500

HOW SUPPLIED

400 mg Capsules (Orange/Orange colored, size '0' hard gelatin capsules with "105" printed on body of capsules containing white to off white granular powder) Bottles of 100 & 500

gab medguide

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LABEL 60

GABAPENTIN 
gabapentin capsule
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:67296-1638(NDC:49483-606)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GABAPENTIN (UNII: 6CW7F3G59X) (GABAPENTIN - UNII:6CW7F3G59X) GABAPENTIN300 mg
Inactive Ingredients
Ingredient NameStrength
STARCH, CORN (UNII: O8232NY3SJ)  
TALC (UNII: 7SEV7J4R1U)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
GELATIN (UNII: 2G86QN327L)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
SHELLAC (UNII: 46N107B71O)  
Product Characteristics
ColoryellowScoreno score
ShapeCAPSULESize19mm
FlavorImprint Code 104
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:67296-1638-220 in 1 BOTTLE; Type 0: Not a Combination Product01/01/2019
2NDC:67296-1638-660 in 1 BOTTLE; Type 0: Not a Combination Product11/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA09000701/01/2019
Labeler - RedPharm Drug, Inc. (828374897)
Establishment
NameAddressID/FEIBusiness Operations
RedPharm Drug, Inc.828374897repack(67296-1638) , relabel(67296-1638)

Revised: 1/2021
Document Id: b8d0a08f-8077-1f4e-e053-2a95a90a62e9
Set id: 88ddd50d-1762-2880-e053-2995a90adf67
Version: 3
Effective Time: 20210113
 
RedPharm Drug, Inc.